Newswise — LOS ANGELES (Jan. 27, 2012) – Asma M. Moheet, MD,
has been named director of Cedars-Sinai Medical Center’s
Neurocritical Care Fellowship program, a two-year training
program for doctors who have completed a neurology residency
and wish to specialize in neurological intensive care.

Moheet is one of three neurointensivists who oversee patient
care in Cedars-Sinai’s highly sophisticated, 12-bed neuro ICU,
which treats a high volume of patients suffering from a range
of neurological and neurosurgical diagnoses.

“As an urban, Level 1 trauma center with a new,
state-of-the-art neuro intensive care unit and 958 licensed
beds, Cedars-Sinai offers an extraordinary learning
environment. Graduates will be prepared to function
independently as intensive care physicians and be qualified to
sit for the Neurocritical Care Board Examination,” Moheet said.

Moheet, a member of the hospital’s Code Brain team that
provides emergency stroke intervention, noted that many
Cedars-Sinai programs – including neurology and neurosurgery –
rank high in U.S. News & World Report’s annual hospital
ratings and other measures of care quality. Cedars-Sinai is a
regional stroke referral center for complicated cases. The
Stroke Program has received the Gold Award from the American
Stroke Association, is certified as a Primary Stroke Center by
The Joint Commission and is an Approved Stroke Center of Los
Angeles County’s Emergency Medical Services Agency.

The fellowship is accredited by the United Council of
Neurologic Subspecialties. Applications for the 2013 position
are being accepted now, with candidate interviews starting this
spring.

Moheet, board certified in neurology, was a clinical fellow and
instructor at the University of California, San Francisco,
before joining Cedars-Sinai in 2010. She received her medical
degree from the University of Missouri, Kansas City, in a
six-year integrated bachelor’s and medical degree program,
completing her internal medicine internship and neurology
residency at the Cleveland Clinic Foundation. She held a
courtesy faculty appointment at the Cleveland Clinic while
pursuing the fellowship in neurovascular and neurocritical care
at UCSF.

Besides caring for patients and teaching, Moheet has research
under way in drug and mechanical interventions for stroke,
brain-monitoring techniques, patient safety and medical ethics.

Cedars-Sinai’s neuro ICU is part of the Department of
Neurology, chaired by Patrick D. Lyden, MD, the Carmen and
Louis Warschaw Chair in Neurology. He is an internationally
known researcher who is leading clinical trials on therapeutic
hypothermia as a way to prevent brain injury following stroke.
He was one of the key researchers in the major clinical trial
leading to Food and Drug Administration approval in 1996 of tPA
– tissue plasminogen activator – still the only proven,
approved drug for stroke treatment.

After joining Cedars-Sinai in 2009, Lyden, an American Academy
of Neurology fellow, reinforced key existing programs and set
the department on a course to expand its research, educational
and clinical offerings. The department will relocate to the
450,000-square-foot Advanced Health Sciences Pavilion when it
opens in 2013.

###

Visit link:
Asma M. Moheet, MD, to Direct Cedars-Sinai's Neurocritical Care Fellowship